PYXIS ONCOLOGY INC (PYXS)

US7473241013 - Common Stock

4.15  -0.02 (-0.48%)

After market: 4.15 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
16.15M0.000.000.000.00
Operating Expenses
82.51M82.20M123.48M69.72M12.89M
Research and Development
50.72M47.89M86.13M51.05M9.05M
Selling, General, and Administrative Expenses
31.81M32.31M37.35M18.66M3.85M
Operating Income
-66.84M-82.20M-123.48M-69.72M-12.89M
Interest Income/Expense
1.04M1.84M2.76M-6.44M70.00K
Other Income/Expense
8.00M6.56M0.00180.00KN/A
Income Before Taxes
-57.80M-73.79M-120.72M-75.98M-12.83M
Net Income
-57.80M-73.79M-120.72M-75.98M-12.83M
EBITDA
-63.99M-80.27M-122.77M-69.07M-12.42M
 
Per Share Data
EPS Diluted Total Ops
-1.38-1.85-3.65-2.36-0.39
Non GAAP EPS
N/A-1.85-3.62N/AN/A
 
Statistics
Profit Margin
-358.00%N/AN/AN/AN/A
Operating Profit Margin
-413.98%N/AN/AN/AN/A

All data in USD

Charts